Howard Capital Management
VRTX icon

Howard Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Howard Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.23M Sell
8,095
-18
-0.2% -$9.22K 0.05% 136
2026
Q2 		$4.03M Buy
8,113
+4,143
+104% +$1.84M 0.05% 125
2026
Q1 		$1.77M Sell
3,970
-5,304
-57% -$2.47M 0.03% 133
2025
Q4 		$4.2M Buy
9,274
+360
+4% +$155K 0.05% 109
2025
Q3 		$3.49M Sell
8,914
-4
-0% -$1.67K 0.05% 118
2025
Q2 		$3.97M Buy
8,918
+2,282
+34% +$1.05M 0.06% 105
2025
Q1 		$3.22M Sell
6,636
-1,021
-13% -$476K 0.08% 102
2024
Q4 		$3.08M Buy
7,657
+224
+3% +$104K 0.05% 111
2024
Q3 		$3.46M Buy
+7,433
New +$3.57M 0.06% 102
2020
Q4 		– Sell
-1,859
Closed -$506K – 65
2020
Q3 		$506K Sell
1,859
-761
-29% -$210K 0.12% 40
2020
Q2 		$768K Buy
+2,620
New +$710K 0.22% 26
2020
Q1 		– Sell
-4,979
Closed -$726K – 48
2019
Q4 		$726K Buy
4,979
+3,472
+230% +$703K 0.25% 17
2019
Q3 		$255K Buy
1,507
+5
+0.3% +$885 0.11% 36
2019
Q2 		$254K Sell
1,502
-127
-8% -$22.2K 0.11% 35
2019
Q1 		$310K Buy
+1,629
New +$301K 0.16% 35

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Howard Capital Management's VRTX Position: Q3 2026 in Review

Howard Capital Management reduced its Vertex Pharmaceuticals (VRTX) stake by 0.22% in Q3 2026, selling an estimated $9.22K and leaving 8,095 shares worth $4.23M. The position accounts for 0.05% of the portfolio, ranked #136.

Howard Capital Management first reported a position in VRTX in Q1 2019 and has held it in 15 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Howard Capital Management held 8,095 shares of Vertex Pharmaceuticals worth $4.23M as of Q3 2026.
  • Howard Capital Management sold 18 Vertex Pharmaceuticals shares in Q3 2026, an estimated $9.22K.
  • Vertex Pharmaceuticals made up 0.05% of Howard Capital Management's portfolio in Q3 2026, its #136 holding.
  • Howard Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 15 quarters since.
  • 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Howard Capital Management's 13F filing for Q3 2026, filed 16 Oct 2026.